Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.19B |
| 2 |
Microsoft
MSFT
|
+$1.07B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.06B |
| 4 |
Tesla
TSLA
|
+$1.01B |
| 5 |
Meta Platforms (Facebook)
META
|
+$691M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$689M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$525M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$450M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$305M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.37% |
| 2 | Financials | 9.02% |
| 3 | Communication Services | 7.25% |
| 4 | Consumer Discretionary | 6.95% |
| 5 | Healthcare | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Greif Class B
GEF.B
$4.12B
| $157K | ﹤0.01% |
2,424
+1,647
| +212% | +$101K |
|
3702
Kartoon Studios
TOON
$35.3M
| $157K | ﹤0.01% |
11,535
+7,964
| +223% | +$124K |
|
3703
Atossa Therapeutics
ATOS
$21.8M
| $156K | ﹤0.01% |
3,187
+1,649
| +107% | +$95.9K |
|
3704
Mistras Group
MG
$483M
| $156K | ﹤0.01% |
15,359
+5,655
| +58% | +$55.8K |
|
3705
TETRA Technologies
TTI
$1.13B
| $156K | ﹤0.01% |
50,304
+34,775
| +224% | +$112K |
|
|
CNCE
3706
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $156K | ﹤0.01% |
47,480
+445
| +0.9% | +$1.56K |
|
3707
Forestar Group
FOR
$1.45B
| $155K | ﹤0.01% |
8,311
-1,064
| -11% | -$21.5K |
|
3708
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.44B
| $155K | ﹤0.01% |
5,535
| – | – |
|
3709
Cartesian Therapeutics
RNAC
$222M
| $155K | ﹤0.01% |
1,237
+268
| +28% | +$32.4K |
|
|
ZIXI
3710
DELISTED
Zix Corporation
ZIXI
| $155K | ﹤0.01% |
21,911
-11,075
| -34% | -$80K |
|
3711
Centrus Energy
LEU
$3.52B
| $154K | ﹤0.01% |
3,965
+2,768
| +231% | +$76.8K |
|
3712
Invesco Semiconductors ETF
PSI
$2.32B
| $154K | ﹤0.01% |
3,609
-1,146
| -24% | -$48.8K |
|
3713
Bridgewater Bancshares
BWB
$561M
| $152K | ﹤0.01% |
8,671
+5,737
| +196% | +$93.1K |
|
3714
Future Fuel
FF
$214M
| $152K | ﹤0.01% |
21,190
+7,706
| +57% | +$64K |
|
3715
Dianthus Therapeutics
DNTH
$5.88B
| $151K | ﹤0.01% |
1,288
-354
| -22% | -$41.2K |
|
3716
LCNB Corp
LCNB
$285M
| $151K | ﹤0.01% |
8,643
+2,687
| +45% | +$45.9K |
|
|
DSKE
3717
DELISTED
Daseke, Inc. Common Stock
DSKE
| $151K | ﹤0.01% |
16,413
+10,483
| +177% | +$87.2K |
|
|
SIEN
3718
DELISTED
Sientra, Inc.
SIEN
| $151K | ﹤0.01% |
2,629
+317
| +14% | +$21.7K |
|
3719
TransAlta
TAC
$4.04B
| $150K | ﹤0.01% |
14,163
+4,599
| +48% | +$46.1K |
|
|
ACH
3720
DELISTED
Alum Corp of China Ltd
ACH
| $150K | ﹤0.01% |
8,006
-11,230
| -58% | -$188K |
|
3721
Foster
FSTR
$430M
| $149K | ﹤0.01% |
9,667
-7,238
| -43% | -$124K |
|
3722
RBB Bancorp
RBB
$444M
| $149K | ﹤0.01% |
5,911
+2,906
| +97% | +$71.2K |
|
3723
USA Compression Partners
USAC
$3.78B
| $149K | ﹤0.01% |
9,001
-2,571
| -22% | -$40.4K |
|
|
DRRX
3724
DELISTED
DURECT Corp
DRRX
| $147K | ﹤0.01% |
11,397
+8,449
| +287% | +$115K |
|
3725
PUT
Duke Energy
DUK
$97.7B
| $146K | ﹤0.01% |
1,500
| – | – |
|
Similar funds
Barclays's Q3 2021 Portfolio in Review
As of Q3 2021, Barclays held 5,157 positions worth $222B, up 5% from $212B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $12.8B of net new capital in Q3 2021, opening 259 new positions and adding to 2,650 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street Technology Select Sector SPDR ETF, an estimated $689M trimmed.
- Barclays's largest Q3 2021 buy was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
- Barclays added most to Amazon in Q3 2021, an estimated $1.19B increase.
- Barclays's biggest Q3 2021 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $689M.
- Barclays fully exited GE Aerospace in Q3 2021, selling an estimated $248M.
- Barclays's ten largest holdings make up 31% of its $222B portfolio in Q3 2021.
- Barclays opened 259 new positions and closed 365 in Q3 2021.
- Barclays's portfolio value rose 5% quarter-over-quarter to $222B.
Based on Barclays's 13F filing for Q3 2021, filed 9 Nov 2021.